Chinese Diabetes Tracking Device Maker Raises Series C Round From CICC Capital

Login to View

Hangzhou Kang Sheng Health Management Consulting Co., a Chinese firm offering diabetes management equipment, has completed a US$100 million series C financing round, totaling from a series C1 and C2 round, according to a today’s statement.

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Want to read this important story?

Access Over 11,000 stories and data posts over the past 8 years!

Register Now


Already have an account or paid subscription? Log in


RELATED NEWS